Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07471971) titled 'Assessment of Hypertensive Retinopathy Using Convolutional Neural Network "RetinAIcheck"' on March 10.

Study Type: Observational

Primary Sponsor: I.M. Sechenov First Moscow State Medical University

Condition: Hypertensive Retinopathy

Intervention: Diagnostic Test: Convolutional neural network "RetinAIcheck"

Recruitment Status: Not recruiting

Date of First Enrollment: March 11, 2021

Target Sample Size: 729

Countries of Recruitment: Russia

To know more, visit https://clinicaltrials.gov/study/NCT07471971

Disclaimer: Curated by HT Syndication....